Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes

Novo Nordisk and Eli Lilly are working to increase supply of their popular weight loss drugs. Meanwhile, the implantable neurotechnology field is heating up.

Previous post Bolts appeared to be missing from Boeing 737 Max door plug that blew off midflight, NTSB says
Next post Alibaba’s stock surges ahead of earnings, and Nio’s bounces sharply off four-year low